Laboratoire Tilman has acquired Promogen
The shareholders of Promogen have sold the company to Laboratoire Tilman.
Founded in 1956, Laboratoire Tilman is a Belgium pharmaceutical laboratory specialized in the development, production and marketing of phytotherapy products and is the leader in the field of medicinal plants in Belgium. The company offers a range of more than 100 natural herbal solutions sold in over 30 countries, including best-selling products such as Flexofytol, Sedistress and Antimetil.
Founded in 2012, Promogen is an external independent French pharmaceutical network that promotes, sells and distributes a diverse portfolio, which includes medicines, medical devices, food supplements and cosmetics, through four brands, in the rheumatology, well-being, dermo-cosmetics, wound healing and fertility therapeutic areas. Promogen distributes its products to over 9,000 pharmacies and drugstores in France, through an in-house sales force of approximately 40 representatives.
Oaklins’ team in France acted as advisor to the shareholders of Laboratoire Tilman in this transaction.
Sprechen Sie mit dem Deal-Team
Transaktionen
CARSO Group has acquired a majority stake in AQCF Group
CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.
Mehr erfahrenPrestige Inhome Care has found a long-term strategic partner
Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.
Mehr erfahrenCara Care wurde von Mahana Therapeutics übernommen
Mahana Therapeutics Inc., ein innovativer Anbieter von digitalen Gesundheitslösungen für chronische Erkrankungen, hat die Übernahme von Cara Care (HiDoc Technologies GmbH) abgeschlossen. Cara Care ist eine führende digitale Gesundheitsplattform und eine offizielle digitale Gesundheitsanwendung (DiGA) zur Verbesserung der Darmgesundheit. Diese Übernahme, die auch von den Investoren Lux Capital und Jazz Ventures Partners unterstützt wird, passt perfekt zur Expansionsstrategie von Mahana.
Mehr erfahren